Jingwu Zhang Zang
Directeur/Membre du Conseil chez HH&L ACQUISITION CO.
Fortune : 7 M $ au 30/04/2024
Postes actifs de Jingwu Zhang Zang
Sociétés | Poste | Début | Fin |
---|---|---|---|
HH&L ACQUISITION CO. | Directeur/Membre du Conseil | 04/02/2021 | - |
Independent Dir/Board Member | 04/02/2021 | - | |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Fondateur | 01/06/2016 | - |
Président | 24/08/2016 | - | |
Directeur Général | 24/08/2016 | - |
Historique de carrière de Jingwu Zhang Zang
Anciens postes connus de Jingwu Zhang Zang
Sociétés | Poste | Début | Fin |
---|---|---|---|
I-MAB | Directeur/Membre du Conseil | 01/10/2019 | 01/03/2021 |
Directeur Général | 01/01/2022 | 30/09/2022 | |
Président | 01/03/2021 | 10/02/2024 | |
Fondateur | 30/06/2016 | 10/02/2024 | |
SIMCERE PHARMACEUTICAL GROUP LIMITED | President | 01/09/2013 | 01/04/2016 |
BioSciKin Co., Ltd.
BioSciKin Co., Ltd. Pharmaceuticals: MajorHealth Technology BioSciKin Co., Ltd. develops drugs and medical products. The private company is based in Nanjing, China. | Directeur Technique/Scientifique/R&D | 01/09/2013 | 01/04/2016 |
President | 01/09/2013 | 01/04/2016 | |
Glaxosmithkline China Ltd. | Directeur Technique/Scientifique/R&D | 01/04/2007 | 01/06/2013 |
Shanghai Jiao Tong University School of Medicine | Corporate Officer/Principal | 01/06/2002 | 01/04/2007 |
Institut Pasteur de Shanghai
Institut Pasteur de Shanghai Miscellaneous Commercial ServicesCommercial Services Institut Pasteur de Shanghai operates as a non-profit life sciences organization. The private company is based in Shanghai, China. | Directeur/Membre du Conseil | 01/10/2004 | 01/09/2006 |
The Institute of Health Sciences | Directeur/Membre du Conseil | - | - |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Jingwu Zhang Zang
Shanghai Jiao Tong University | Doctorate Degree |
Vrije Universiteit Brussel | Doctorate Degree |
Statistiques
Internationale
Chine | 9 |
Etats-Unis | 4 |
Belgique | 2 |
Opérationnelle
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
President | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 5 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
SIMCERE PHARMACEUTICAL GROUP LIMITED | Health Technology |
I-MAB | Health Technology |
Entreprise privées | 7 |
---|---|
Opexa Pharmaceuticals, Inc. | Health Technology |
Institut Pasteur de Shanghai
Institut Pasteur de Shanghai Miscellaneous Commercial ServicesCommercial Services Institut Pasteur de Shanghai operates as a non-profit life sciences organization. The private company is based in Shanghai, China. | Commercial Services |
Glaxosmithkline China Ltd. | |
The Institute of Health Sciences | |
BioSciKin Co., Ltd.
BioSciKin Co., Ltd. Pharmaceuticals: MajorHealth Technology BioSciKin Co., Ltd. develops drugs and medical products. The private company is based in Nanjing, China. | Health Technology |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
HH&L Acquisition Co.
HH&L Acquisition Co. Financial ConglomeratesFinance HH&L Acquisition Co. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on September 4, 2020 and is headquartered in Hong Kong. | Finance |
- Bourse
- Insiders
- Jingwu Zhang Zang
- Expérience